Business News • MarketWire • VenGrowth Announces Investment Team Changes and Continues Periodic Distribution Strategy for VGI, VGII and VGALS |
VenGrowth Announces Investment Team Changes and Continues Periodic Distribution Strategy for VGI, VGII and VGALS |
|
|
VenGrowth Announces Investment Team Changes and Continues Periodic Distribution Strategy for VGI, VGII and VGALS
TORONTO, ONTARIO--(Marketwire - Dec. 24, 2010) - VenGrowth Asset Management Inc. today announced that Michael Cohen and Dr. Cynthia Lavoie will head up the investment team for the VenGrowth Advanced Life Sciences Fund Inc. ("VGALS") Michael Cohen has been with VenGrowth as a Managing General Partner since the inception of the retail venture funds in 1994. He has invested over $188 million in 17 companies, including companies in the health care sector. Michael has chaired the life sciences investment committee since the discipline was added to VenGrowth in 2002. Dr. Lavoie, a Partner at VenGrowth, has been an integral member of the life sciences investment discipline since joining VenGrowth in 2003. Cynthia holds a B.Sc. (Honours) in Biology, an MBA and a Ph.D. in Molecular and Cellular Biology. Michael and Cynthia succeed Dr. Luc Marengère who has left to pursue new business interests. We would like to thank Luc for his
View More : http://www.marketwire.com/mw/release.do?id=1373702&sourceType=3
|
|
|